Arab Company for Pharmaceutical Products

Arabio (Arab Company for Pharmaceutical Products) is a prominent biopharmaceutical company headquartered in Riyadh, Saudi Arabia, focused on the production and supply of vaccines and biological products. As the first facility in the Gulf region dedicated to human vaccines, it plays a critical role in regional health security and self-sufficiency. The company operates through strategic alliances with global leaders such as GSK and Sanofi, facilitating the local manufacturing and packaging of essential immunizations. Arabio's portfolio covers a wide range of therapeutic areas, including infectious diseases like meningitis and hepatitis. The company is a joint venture primarily owned by the Arab Company for Drug Industries and Medical Appliances (ACDIMA) and the Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO). Its state-of-the-art manufacturing site is designed to meet international GMP standards, supporting both local demand and export markets across the MENA region.